tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Balance Sheet

Compare
312 Followers

TScan Therapeutics Balance Sheet

TScan Therapeutics's total assets for Q3 2025 were $262.23M, a decrease of 0.00% from the previous quarter. TCRX total liabilities were $118.20M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 371.12M$ 272.15M$ 199.09M$ 188.11M$ 49.74M
Total Liabilities
$ 130.15M$ 121.28M$ 99.66M$ 27.33M$ 92.20M
Total Equity Gross Minority
$ 240.97M$ 150.87M$ 99.43M$ 160.78M$ -42.46M
Other Metrics
Currency in USD

TScan Therapeutics Debt to Assets